Go to deals
Private Equity | Alimentação & Bebidas

Ñaming, SL has been acquired by DeA Capital S.p.A.

Spain’s leading producer of sandwiches, fresh and ultra-fresh products, Ñaming, has sold a majority stake to Italian fund DeA Capital.

Founded in 1990 and headquartered in Zaragoza, Spain, Ñaming is a manufacturer and supplier of fresh single-dose foods for supermarkets, gas stations and vending machines. A market leader in the Spanish sandwich segment, it offers a wide range of products, including yogurts, juices, salads and cut fruit. Ñaming’s activities encompass both production and distribution, supported by its own nationwide distribution network.

DeA Capital is an Italian fund with more than €28 billion (US$30 billion) of assets under management. The firm has Agostini Group, one of Italy’s largest unlisted family-owned holding companies, as a major investor. DeA Capital currently manages the Taste of Italy 2 fund, which specializes in the food sector.

Founded in 1976 and based in Bilbao, Talde is a Spanish private equity fund with approximately €380 million (US$415 million) in assets under management aimed at both private equity and private debt. The firm focuses on the Spanish low–middle market.

Oaklins’ team in Spain advised Ñaming on all aspects of the design, execution, negotiation and closing of the transaction.

Entidades

Falar com a equipa da transação

José Antonio Martín de los Santos

Partner
Madrid, Espanha
Oaklins SOCIOS

Mark Parson

Managing Partner
Madrid, Espanha
Oaklins SOCIOS

Transações relacionadas

ELSA Group has sold SoFine Foods to The New Originals Company
Alimentação & Bebidas

ELSA Group has sold SoFine Foods to The New Originals Company

The New Originals Company has acquired SoFine Foods from the ELSA Group.

Saber mais
Den Berk Délice accelerates growth through strategic partnership
Private Equity | Agricultura

Den Berk Délice accelerates growth through strategic partnership

Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.

Saber mais
Xiel Limited has been acquired by MIS Healthcare
Private Equity | Saúde

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Saber mais